HAP Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,200
Closed -$2K 1831
2022
Q3
$2K Sell
26,200
-2,200
-8% -$11.3K ﹤0.01% 1601
2022
Q2
$5K Sell
28,400
-6,400
-18% -$27.7K ﹤0.01% 1631
2022
Q1
$13K Sell
34,800
-10,500
-23% -$62.4K ﹤0.01% 1711
2021
Q4
$17K Buy
45,300
+18,900
+72% +$164K ﹤0.01% 1876
2021
Q3
$7K Sell
26,400
-6,400
-20% -$63.3K ﹤0.01% 2112
2021
Q2
$33K Buy
32,800
+11,400
+53% +$129K ﹤0.01% 1640
2021
Q1
$39K Sell
21,400
-53,000
-71% -$714K ﹤0.01% 1235
2020
Q4
$265K Buy
74,400
+30,100
+68% +$353K 0.01% 856
2020
Q3
$42K Sell
44,300
-1,800
-4% -$19.5K ﹤0.01% 1010
2020
Q2
$52K Buy
+46,100
New +$428K ﹤0.01% 1030
2020
Q1
Sell
-65,100
Closed -$31K 1483
2019
Q4
$31K Sell
65,100
-12,300
-16% -$113K ﹤0.01% 795
2019
Q3
$45K Buy
77,400
+25,300
+49% +$284K ﹤0.01% 757
2019
Q2
$94K Sell
52,100
-10,000
-16% -$106K 0.01% 620
2019
Q1
$58K Buy
+62,100
New +$634K 0.01% 642
2016
Q4
Sell
-48,000
Closed -$12K 1194
2016
Q3
$12K Buy
48,000
+1,700
+4% +$8.65K ﹤0.01% 959
2016
Q2
$43K Buy
46,300
+300
+0.7% +$1.91K ﹤0.01% 624
2016
Q1
$76K Buy
+46,000
New +$276K 0.01% 488

Other funds holding SGMO

HAP Trading's SGMO Position: Q2 2019 in Review

HAP Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 23,358 shares — an estimated $248K sold.

HAP Trading first reported a position in SGMO in Q4 2018 and held it in 2 quarters. The position peaked at $259K in Q4 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • HAP Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • HAP Trading sold 23,358 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $248K.
  • HAP Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 2 quarters.
  • HAP Trading's SANGAMO THERAPEUTICS INC position peaked at $259K in Q4 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on HAP Trading's 13F filing for Q2 2019, filed 14 Aug 2019.